Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide

Gut

Volumn 52, Issue 3, 2003, Pages 410-415

  Helmy, A ^a,b   Newby, D E ^a   Jalan, R ^a,c   Hayes, P C ^a   Webb, D J ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM;

ADULT; ANTIOXIDANT ACTIVITY; ARTERY CLAMP; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG MECHANISM; FEMALE; FOREARM BLOOD FLOW; HEART INDEX; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

EID: 0037369631     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.3.410     Document Type: Article

References (47)

1. Murray JF, Dowson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med 1958;32:358-67.
2. Kontos HA, Shapiro W, Mauck HP, et al. General and regional circulatory alterations in cirrhosis of the liver. Am J Med 1964;37:526-35.
3. Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 1953;32:1025-33.
4. Braillon A, Cales P, Valla D, et al. Influence of the degree of liver failure on the systemic and splanchnic haemodynamics and on the response to propranolol in patients with cirrhosis. Gut 1986;27:1206-9.
5. Schrier RW, Arroyo V, Bernordi M, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-7.
6. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-15.
7. Arai H, Hori S, Aramori I, et al. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730-2.
8. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning a cDNA encoding non- isopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732-5.
9. Spokes RA, Ghatei MA, Bloom SR. Studies with endothelin-3 and endothelin-1 on rat blood pressure and isolated tissues: evidence for endothelin receptor subtypes. J Cardiovasc Pharmacol 1989;13:S191-2.
10. A subtype. Br J Pharmacol 1995;114:1110-6.
11. B receptors cause vasoconstriction in human resistance and capacitance vessels in vivo. Circulation 1995;92:357-63.
12. A receptors in humans? Trends Pharmacol Sci 1994;15:9-11.
13. Takayanagi R, Kitazumi K, Takasaki C, et al. Presence of a non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilatation. FEBS Lett 1991;282:103-6.
14. Helmy A, Jalan R, Newby DE, et al. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis. Hepatology 2001;33:826-31.
15. Verhaar MC, Strachan FE, Newby DE, et al. Endothelin-A receptor antagonist- mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 1998;97:752-6.
16. Berrazueta JR, Bhagat K, Vallance P, et al. Dose- and time-dependency of the dilator effects of the endothelin antagonist, BQ- 123, in the human forearm. Br J Clin Pharmacol 1997;44:569-71.
17. Martin P, Gines P, Schrier RW. Nitric oxide as a mediator of haemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998;339:533-41.
18. Howes LG, Reid JL. Decreased vascular responsiveness to noradrenaline following regular ethanol consumption. Br J Clin Pharmacol 1985;20:669-74.
19. Rankin LI, Luft FC, Henry DP, et al. Sodium intake alters the effects of noradrenaline on blood pressure. Hypertension 1981;3:650-6.
20. Hashimoto M, Akishita M, Eto M. Modulation of endothelium-dependent flow- mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995;92:3431-5.
21. Spratt JC, Goddard J, Patel N, et al. Systemic ETA receptor antagonism with BQ- 123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Br J Pharmacol 2001;134:648-54.
22. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;28:997-1000.
23. Calver A, Harris A, Maxwell JD, et al. Effect of local inhibition of nitric oxide synthesis on forearm blood flow and dorsal hand vein size in patients with alcoholic cirrhosis. Clin Sci 1994;86:203-8.
24. Appel PL, Kram HB, Mackabee J, et al. Comparison of measurements of cardiac output by bioimpedance and thermodilution in severely ill surgical patients. Crit Care Med 1986;14:933-5.
25. Northridge DB, Findlay IN, Wilson J, et al. Non-invasive determination of cardiac output by Doppler echocardiography and electrical bioimpedance. Br Heart J 1990;63:93-7.
26. Wiinberg N, Walter-Larsen S, Eriksen C, et al. An evaluation of semi-automatic blood pressure manometers against intra-arterial blood pressure. J Amb Monit 1988;1:303-9.
27. Newby DE, Jalan R, Masumori S, et al. Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous system. Cardiovasc Res 1998;38:221-8.
28. Helmy A, Jalan R, Newby DE, et al. Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in patients with early and advanced cirrhosis. Gastroenterology 2000;118:565-72.
29. Stroes ESG, Luscher TF, deGroot FG, et al. Cyclosporin A increases nitric oxide activity in vivo. Hypertension 1997;29:570-5.
30. Rolinski B, Sadri I, Bogner J, et al. Determination of endothelin-1 immunoreactivity in plasma, cerebrospinal fluid and urine. Res Exp Med 1994;194:9-24.
31. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (London) 1953;121:1-27.
32. Kerslake DM. The effect of the application of an arterial occlusion cuff to the wrist on the blood flow in the human forearm. J Physiol (London) 1949;108:451-7.
33. Benjamin N, Calver A, Collier J, et al. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995;25:918-23.
34. Hocher B, Thone-Reineke C, Bauer C, et al. The paracrine endothelin system: pathophysiology and implications in clinical medicine. Eur J Clin Chem Clin Biochem 1997;35:175-89.
35. Frelin C, Guedin D. Why are circulating concentrations of endothelin-1 so low? Cardiovasc Res 1994;28:1613-22.
36. Strachan FE, Spratt JC, Wilkinson IB, et al. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy man. Hypertension 1999;33:581-5.
37. De Nucci G, Thomas R, D'Orleans-Juste P, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 1988;85:9797-800.
38. Barriere E, Tazi KA, Rona JP, et al. Evidence for an endothelium-derived hyperpolarizing factor in the superior mesenteric artery from rats with cirrhosis. Hepatology 2000;32:935-41.
39. Batkai S, Jarai Z, Wagner JA, et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 2001;7:827-32.
40. Ryan J, Jennings G, Dudley F, et al. Smooth muscle-derived nitric oxide is elevated in isolated forearm veins in human alcoholic cirrhosis. Clin Sci 1996;91:23-8.
41. Chowienczyk PJ, Watts GF, Cockcroft JR, et al. Impaired endothelium-dependent vasodilatation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992;340:1430-32.
42. Stroes ES, Koomans HA, de Bruin TWA, et al. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 1995;346:467-71.
43. Wang F, Liu P, Tobe S, et al. Central blood volume in cirrhosis: measurement with radionuclide angiography. Hepatology 1994;19:312-21.
44. Lewis FW, Adair O, Rector WG. Arterial vasodilatation is not the cause of increased cardiac output in cirrhosis. Gastroenterology 1992;102:1024-9.
45. Gentilini P, Romanelli RG, Laffi G, et al. Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. J Hepatol 1999;30:632-8.
46. Bernardi M, Di Marco C, Trevisani F, et al. The haemodynamic status of pre-ascitic cirrhosis: an evaluation under steady state condition and after pastural change. Hepatology 1992;16:341-6.
47. Maroto A, Gines P, Arroyo V, et al. Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction. Hepatology 1993;17:788-93.